NASDAQ · Hardware, Equipment & Parts

OST (OST) Stock

$1.70 +0.00% NASDAQ: OST Technology

Valuation

MetricValue
Price$1.70
Market Cap$10.11M
P/E Ratio-0.39
P/B Ratio1.44
P/S Ratio0.25
EPS (TTM)$-4.38
52-Week High$235.00
52-Week Low$1.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-142.86%
ROA-18.87%
ROCE-81.82%
Gross Margin-22.50%
Operating Margin-22.50%
Net Margin-25.24%
Debt/Equity3.66
Current Ratio0.45

Annual Financials (USD)

Metric20212022202320242025
Revenue$168.0M$105.0M$58.0M$32.0M$40.0M
Operating Profit$3.0M$0$-10.0M$-10.0M$-9.0M
Net Profit$3.0M$0$-11.0M$-10.0M$-10.0M
EPS$14347.50$1062.50$-195.00$-168.50$-4.38
Op Margin1.9%0.4%-17.8%-29.4%-22.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$76.0M$57.0M$57.0M$51.0M$53.0M
Total Liabilities$61.0M$32.0M$42.0M$43.0M$42.0M
Cash$1.0M$4.0M$1.0M$1.0M$5.0M
Borrowings$36.0M$22.0M$29.0M$33.0M$26.0M

Latest News

OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program TMX Newsfile · Jul 8, 2026 OS Therapies Third Quarter 2026 Corporate Outlook TMX Newsfile · Jul 6, 2026 OS Therapies Appoints Dr. Craig Eagle to Board of Directors TMX Newsfile · Jul 2, 2026 OS Therapies Provides U.S. Regulatory Update TMX Newsfile · Jun 30, 2026 OS Animal Health Announces Peer-Reviewed Publication of Clinical Trial Data for OST-HER2 Plus Palliative Radiation as Frontline Treatment in Canine Osteosarcoma TMX Newsfile · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$10.0M$-3.0M$-5.0M$0
Investing Cash Flow$-11.0M$-12.0M$-11.0M$-4.0M$-14.0M
Financing Cash Flow$2.0M$-3.0M$2.0M$1.0M$1.0M
Net Cash Flow$-5.0M$3.0M$-3.0M$0$4.0M
Free Cash Flow$-24.0M$5.0M$-7.0M$-7.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield0.00%
Quick Ratio0.26
Interest Coverage-4.50
Return 1Y-45.32%
Return 3Y-99.22%
Return 5Y—

Ownership

Insiders Held15.79%
Institutions Held1.37%
Institutions Float Held1.63%
Institutional HolderSharesReport Date
Citadel Advisors Llc34,6522026-03-31
FNY Investment Advisers, LLC23,1632026-06-30
HRT Financial LP13,5512026-03-31
UBS Group AG2,6562026-03-31
Wells Fargo & Company1602026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
FIEE $2.99 -1.64% 68.80 $11.10M 0.00%
IFBD $1.09 +1.87% -0.12 $8.93M 0.00%
IOTRiOThree Limited Ordinary Shares $2.71 +1.12% -11.75 $8.22M 0.00%
MITQ $0.52 +1.96% -6.10 $5.17M 0.00%
OPTX $7.89 +6.62% -143.20 $317.81M 0.00%

About OST

OST is led by CEO Tao Ling, employs 117 people, headquartered in CN, publicly traded since 2022.

OST stock trades at $1.70 with a market capitalization of $10.11M. The stock is valued at a price-to-earnings (P/E) ratio of -0.39, price-to-book of 1.44, price-to-sales of 0.25. Over the past 52 weeks the stock has ranged between $1.35 and $235.00, and currently trades 99.3% below its 52-week high.

On profitability, OST generates a return on equity (ROE) of -142.86%, return on capital employed of -81.82%, an operating margin of -22.50%, a net profit margin of -25.24%.

Related Technology Stocks

NVDA Semiconductors $223.96 +2.27% AAPL Consumer Electronics $313.33 +0.29% MSFT Software - Infrastructure $499.99 +0.03% AVGO Semiconductors $427.76 +1.71% TSM Semiconductors $374.67 -4.50% MU Semiconductors $739.00 -9.94% AMD Semiconductors $483.36 -1.21% ASML Semiconductors $1550.69 -2.04% INTC Semiconductors $101.65 +1.84% CSCO Communication Equipment $120.59 -0.24% ORCL Software - Infrastructure $146.94 +2.42% AMAT Semiconductors $436.45 -8.40%

Popular Stocks

Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Eli Lilly (LLY)JPMorgan (JPM)Visa (V)Exxon Mobil (XOM)Walmart (WMT)UnitedHealth (UNH)

Screens featuring this stock

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides